Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J van der Mooren

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Clinical Chemistry and Laboratory Medicine|October 11, 2001
Homocysteine in postmenopausal women and the importance of hormone replacement therapyV Mijatovic, M J van der Mooren
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 24, 2004
The Million Women Study: a licence to kill other investigations?M J van der Mooren, P Kenemans
Maturitas|May 1, 1994
Effect of conjugated estrogens with and without medrogestone: a prospective studyM J van der Mooren, J A Leuven, R Rolland
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 1, 1997
Hormone replacement therapy and cardioprotection: basic concepts and clinical considerationsA Pines, V Mijatovic, M J van der Mooren, et al.
Fertility and Sterility|September 1, 1995
The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative studyJ A Gevers Leuven, M J van der Mooren, R Buytenhek
The British Journal of Clinical Practice|January 1, 1997
A randomised study to compare the efficacy and safety of new 17 beta-oestradiol transdermal matrix patch with Estraderm TTS 50 in hysterectomised postmenopausal women. The Lyrelle Study GroupF al-Azzawi, M J Van der Mooren, R Rolland, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 19, 1992
Beneficial effects on serum lipoproteins by 17 beta-oestradiol-dydrogesterone therapy in postmenopausal women; a prospective studyM J van der Mooren, P N Demacker, C M Thomas, et al.
Maturitas|June 8, 2001
Perspectives in hormone replacement therapyP Kenemans, G A van Unnik, V Mijatovic, et al.
Maturitas|December 1, 1994
Changes in the withdrawal bleeding pattern and endometrial histology during 17 beta-estradiol-dydrogesterone therapy in postmenopausal women: a 2 year prospective studyM J van der Mooren, A G Hanselaar, G F Borm, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|September 25, 2003
Estrogens, homocysteine, vasodilatation and menopause: basic mechanisms, interactions and clinical implicationsR G V Smolders, M J van der Mooren, P Sipkema, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Clinical Chemistry and Laboratory Medicine|October 11, 2001
Homocysteine in postmenopausal women and the importance of hormone replacement therapyV Mijatovic, M J van der Mooren
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 24, 2004
The Million Women Study: a licence to kill other investigations?M J van der Mooren, P Kenemans
Maturitas|May 1, 1994
Effect of conjugated estrogens with and without medrogestone: a prospective studyM J van der Mooren, J A Leuven, R Rolland
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 1, 1997
Hormone replacement therapy and cardioprotection: basic concepts and clinical considerationsA Pines, V Mijatovic, M J van der Mooren, et al.
Fertility and Sterility|September 1, 1995
The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative studyJ A Gevers Leuven, M J van der Mooren, R Buytenhek
The British Journal of Clinical Practice|January 1, 1997
A randomised study to compare the efficacy and safety of new 17 beta-oestradiol transdermal matrix patch with Estraderm TTS 50 in hysterectomised postmenopausal women. The Lyrelle Study GroupF al-Azzawi, M J Van der Mooren, R Rolland, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 19, 1992
Beneficial effects on serum lipoproteins by 17 beta-oestradiol-dydrogesterone therapy in postmenopausal women; a prospective studyM J van der Mooren, P N Demacker, C M Thomas, et al.
Maturitas|June 8, 2001
Perspectives in hormone replacement therapyP Kenemans, G A van Unnik, V Mijatovic, et al.
Maturitas|December 1, 1994
Changes in the withdrawal bleeding pattern and endometrial histology during 17 beta-estradiol-dydrogesterone therapy in postmenopausal women: a 2 year prospective studyM J van der Mooren, A G Hanselaar, G F Borm, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|September 25, 2003
Estrogens, homocysteine, vasodilatation and menopause: basic mechanisms, interactions and clinical implicationsR G V Smolders, M J van der Mooren, P Sipkema, et al.
Pageof 6